Annual report pursuant to Section 13 and 15(d)

Note 10 - Stockholders Deficit (Details Textual)

v3.24.0.1
Note 10 - Stockholders Deficit (Details Textual) - USD ($)
12 Months Ended
Sep. 27, 2021
Jul. 30, 2021
Sep. 30, 2023
Sep. 30, 2022
Common Stock, Par or Stated Value Per Share     $ 0.001 $ 0.001
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross     24,500 6,625
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price     $ 8 $ 6
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum     102.80% 86.80%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum     103.40% 98.50%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum     3.80% 1.50%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum     4.00% 3.50%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate     0.00% 0.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares     82,940  
Research and Development Expense [Member]        
Share-Based Payment Arrangement, Expense     $ 57,000 $ 148,000
General and Administrative Expense [Member]        
Share-Based Payment Arrangement, Expense     $ 189,000 $ 311,000
Minimum [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term     4 years 1 month 6 days 3 years 7 months 6 days
Maximum [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term     5 years 9 months 18 days 5 years 9 months 18 days
Employees Directors And Consultants [Member]        
Share-Based Payment Arrangement, Expense     $ 246,000 $ 459,000
The 2013 Plan [Member]        
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price     $ 8.02 $ 10.02
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Aggregate Grant Date Fair Value     $ 156,275 $ 47,609
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount     $ 162,000  
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition     1 year 9 months 18 days  
The 2013 Plan [Member] | Board Of Directors And Management [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross     20,875 2,375
The 2013 Plan [Member] | Consultants [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross     3,625 4,250
Series G and Series H Warrants [Member]        
Shares Issued From Exchange of Warrants     12,019  
Second and Third Closing Notes [Member]        
Debt Conversion, Converted Instrument, Shares Issued     20,210  
Conversion of Series 1 Convertible Notes Into Common Stock [Member]        
Debt Conversion, Converted Instrument, Shares Issued     59,912  
Restricted Stock [Member]        
Stock Issued During Period, Shares, Restricted Stock Award, Gross     250  
Restricted Stock [Member] | The 2013 Plan [Member] | Share-Based Payment Arrangement, Tranche One [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares   250    
Restricted Stock [Member] | The 2013 Plan [Member] | Share-Based Payment Arrangement, Employee [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted   750    
Restricted Stock [Member] | The 2013 Plan [Member] | Consultants [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted 1,500      
Share-Based Payment Arrangement, Option [Member] | The 2013 Plan [Member] | Board Of Directors And Management [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period     36 months 36 months
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period     10 years 10 years
Share-Based Payment Arrangement, Option [Member] | The 2013 Plan [Member] | Consultants [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period     12 months 12 months
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period     5 years 5 years
Non Employee Restricted Shares [Member]        
Share-Based Payment Arrangement, Expense     $ 3,000 $ 40,000
All Stock Issuances [Member]        
Stock Issued During Period, Shares, New Issues     3,436,712  
Financing Activities With Accredited Investors [Member]        
Stock Issued During Period, Shares, New Issues     3,344,321  
Proceeds from Issuance or Sale of Equity     $ 2,209,839